Strata Skin Sciences (SSKN) Stock Price, News & Analysis

Company Overview

Strata Skin Sciences, formerly known as MELA Sciences, is a medical technology company specializing in the development and commercialization of innovative dermatology products. Founded in the early 1990s and rebranded in 2016, the company focuses on advancing treatments for a range of skin conditions by leveraging patented electrical and light-based therapies. Headquartered in Horsham, Pennsylvania, Strata Skin Sciences has established a reputation for delivering novel solutions that address both chronic and acute dermatological needs.

The company’s flagship offering is the XTRAC® phototherapy system, designed to treat psoriasis, eczema and vitiligo through targeted ultraviolet light. XTRAC utilizes a monochromatic excimer laser to deliver high-dose, precision light energy directly to affected areas while minimizing overall UV exposure. This approach has positioned XTRAC as a leading in-office treatment option for patients and clinicians seeking alternatives to systemic therapies or broad-band UV exposure.

In addition to phototherapy, Strata Skin Sciences markets a portfolio of surgical and tissue management devices for Mohs micrographic surgery. Its MohsCold® cryosurgical instruments and disposable tips are engineered to optimize tissue preservation and operator efficiency during skin cancer removal procedures. The company continues to expand its pipeline by exploring complementary technologies that support both diagnostic and therapeutic workflows in dermatology clinics.

Strata Skin Sciences distributes products across North America and Europe, supporting a network of hospitals, dermatology practices and specialty treatment centers. The organization is guided by an experienced leadership team with deep expertise in medical devices, clinical development and commercial strategy. By combining scientific innovation with targeted outreach and training programs, Strata aims to improve patient care and drive wider adoption of advanced dermatologic therapies.

Key Stats

• Today's Range: $2.35 to $2.53
• 50-Day Range: $2.20 to $2.90
• 52-Week Range: $2.10 to $3.80
• Volume: 28,004 shs
• Average Volume: 14,076 shs
• Market Capitalization: $9.88 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.00
• Consensus Rating: Buy

Strata Skin Sciences Stock Analysis - MarketRank™

Strata Skin Sciences scored higher than 67% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Strata Skin Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Strata Skin Sciences has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Strata Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Strata Skin Sciences is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Strata Skin Sciences is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Strata Skin Sciences has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.14% of the float of Strata Skin Sciences has been sold short.

Short Interest Ratio / Days to Cover

Strata Skin Sciences has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Strata Skin Sciences has recently decreased by 11.90%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Strata Skin Sciences does not currently pay a dividend.

Dividend Growth

Strata Skin Sciences does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.14% of the float of Strata Skin Sciences has been sold short.

Short Interest Ratio / Days to Cover

Strata Skin Sciences has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Strata Skin Sciences has recently decreased by 11.90%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.93

News Sentiment

Strata Skin Sciences has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Strata Skin Sciences this week, compared to 1 article on an average week.

Search Interest

1 people have searched for SSKN on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Strata Skin Sciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

39.00% of the stock of Strata Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 32.43% of the stock of Strata Skin Sciences is held by institutions.

SSKN Stock Analysis - Frequently Asked Questions

How have SSKN shares performed this year?

Strata Skin Sciences' stock was trading at $2.91 at the beginning of 2025. Since then, SSKN shares have decreased by 18.6% and is now trading at $2.37.

How were Strata Skin Sciences' earnings last quarter?

Strata Skin Sciences, Inc. (NASDAQ:SSKN) released its earnings results on Wednesday, May, 14th. The medical device company reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.56) by $0.02. The medical device company earned $6.81 million during the quarter, compared to analyst estimates of $7.28 million. Strata Skin Sciences had a negative net margin of 27.22% and a negative trailing twelve-month return on equity of 138.22%.
Read the conference call transcript.

When did Strata Skin Sciences' stock split?

Shares of Strata Skin Sciences reverse split on Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Strata Skin Sciences?

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Strata Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 7/13/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SSKN
• CIK: 1051514
• Web: www.strataskinsciences.com
• Phone: (215) 619-3200
• Fax: 215-619-3208
• Employees: 120
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Strata Skin Sciences: $6.00
• High Price Target: $6.00
• Low Price Target: $6.00
• Potential Upside/Downside: +153.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.09 million
• Net Margins: -27.22%
• Pretax Margin: -27.72%
• Return on Equity: -138.22%
• Return on Assets: -24.37%

Debt

• Debt-to-Equity Ratio: 5.71
• Current Ratio: 1.05
• Quick Ratio: 0.87

Sales & Book Value

• Annual Sales: $33.56 million
• Price / Sales: 0.29
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.19 per share
• Price / Book: 1.99

Miscellaneous

• Outstanding Shares: 4,170,000
• Free Float: 2,544,000
• Market Cap: $9.88 million
• Optionable: Not Optionable
• Beta: 0.69